Your Messages Inbox
Your Article Summary
See Latest ArticlesStatement on FOSAMAX (alendronate sodium) Product Liability Trial in U.S. District Court
Merck & Co., 08/12/09
Merck and Co., Inc. will vigorously defend itself in a jury trial set to begin, in the United States District Court for the Southern District of New York. The company believes the evidence will show that FOSAMAX did not cause Shirley Boles to develop dental and jaw–related problems as she claims and that Merck provided appropriate and timely information about FOSAMAX to the medical, scientific and regulatory communities.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Amgen, 12/08/09
Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
b3c newswire, 12/07/09
Nursing I.T. Award Deadline Near
HealthDataManagement, 12/07/09
Article Search
Sponsor